Testing effectiveness (Phase 2)Study completedNCT02586792What this trial is testingH7N9 Boost in Healthy AdultsWho this might be right forInfluenza National Institute of Allergy and Infectious Diseases (NIAID) 27
Testing effectiveness (Phase 2)Study completedNCT00280033What this trial is testingH5 Adult - Chiron Study of Bird Flu VaccineWho this might be right forInfluenza National Institute of Allergy and Infectious Diseases (NIAID) 394
Early research (Phase 1)Study completedNCT00110279What this trial is testingSafety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study A)Who this might be right forInfluenzaVirus Diseases National Institute of Allergy and Infectious Diseases (NIAID) 30
Early research (Phase 1)Study completedNCT00488046What this trial is testingSingle Group Study of the Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy AdultsWho this might be right forInfluenzaVirus Diseases National Institute of Allergy and Infectious Diseases (NIAID) 16
Large-scale testing (Phase 3)Study completedNCT01788228What this trial is testingSafety and Tolerability Study of GlaxoSmithKline (GSK)1557484A Vaccine in Adults at Occupational Risk for Influenza A (H5N1) ExposureWho this might be right forInfluenzaInfluenza Vaccines GlaxoSmithKline 50
Testing effectiveness (Phase 2)Study completedNCT03497845What this trial is testingAssess the Safety & Immunogenicity of Prime-Boost Vaccination Strategies Using H5Nx Virus Vaccine Adjuvanted With AS03 or MF59Who this might be right forInfluenza A Virus, H5N1 Subtype Biomedical Advanced Research and Development Authority 720
Early research (Phase 1)Study completedNCT02171819What this trial is testingInfluenza A/H5N1 Vaccine Clinical Trial (IVACFLU-A/H5N1) - Phase 1Who this might be right forInfluenza A Subtype H5N1 Infection Institute of Vaccines and Medical Biologicals, Vietnam 75
Testing effectiveness (Phase 2)Study completedNCT00382187What this trial is testingSafety and Immunogenicity of Two Adjuvanted and One Non-adjuvanted H5N1 Influenza Vaccine in AdultsWho this might be right forInfluenza Novartis Vaccines 40
Testing effectiveness (Phase 2)Ended earlyNCT00383071What this trial is testingDevelopment of Immune Globulin Treatment for Avian FluWho this might be right forInfectious DiseasesInfluenzaAvian Flu National Institute of Allergy and Infectious Diseases (NIAID) 126
Early research (Phase 1)Study completedNCT00516035What this trial is testingSingle Group Study of the Safety of and Immune Response to a Bird Flu Vaccine (H7N3) in Healthy AdultsWho this might be right forInfluenzaVirus Diseases National Institute of Allergy and Infectious Diseases (NIAID) 22
Early research (Phase 1)Study completedNCT00380237What this trial is testingSafety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study B)Who this might be right forInfluenzaVirus Diseases National Institute of Allergy and Infectious Diseases (NIAID) 20
Testing effectiveness (Phase 2)Study completedNCT02921997What this trial is testingH7N9 Vaccination With and Without AS03 and Unadjuvanted H3N2v Vaccination: Standard and Systems Biology AnalysesWho this might be right forAvian InfluenzaH1N1 InfluenzaInfluenza National Institute of Allergy and Infectious Diseases (NIAID) 30
Early research (Phase 1)Study completedNCT00734175What this trial is testingSafety of and Immune Response to Recombinant Live-Attenuated Influenza H6N1 Virus Vaccine VaccineWho this might be right forInfluenzaVirus Diseases National Institute of Allergy and Infectious Diseases (NIAID) 22
Large-scale testing (Phase 3)Study completedNCT00319098What this trial is testingStudy to Evaluate the Safety and Immunogenicity of a Pandemic Influenza Vaccine in Adults Aged 18 Years and AboveWho this might be right forInfluenza GlaxoSmithKline 5,075
Testing effectiveness (Phase 2)Study completedNCT00294099What this trial is testingH5 Vaccine Alone or With Aluminum Hydroxide in Elderly AdultsWho this might be right forInfluenza National Institute of Allergy and Infectious Diseases (NIAID) 600
Testing effectiveness (Phase 2)Study completedNCT00298233What this trial is testingHigh-Dose Versus Standard-Dose Oseltamivir to Treat Severe Influenza and Avian InfluenzaWho this might be right forInfluenzaAvian InfluenzaSevere Influenza National Institute of Allergy and Infectious Diseases (NIAID) 326
Early research (Phase 1)Study completedNCT01698060What this trial is testingImmunogenicity of ND1.1 by Delivery Directly to the IleumWho this might be right forAvian Influenza Vaxart 12
Testing effectiveness (Phase 2)Study completedNCT01147068What this trial is testingSafety and Immunogenicity of PanBlok Influenza Vaccine in Healthy AdultsWho this might be right forInfluenza Protein Sciences Corporation 392
Early research (Phase 1)Study completedNCT01596725What this trial is testingA/H5N1 Virus-Like Particle Antigen Dose Ranging Study With Adjuvant 2Who this might be right forInfluenza (Pandemic) Novavax 333
Early research (Phase 1)Study completedNCT00664417What this trial is testingStudy of Different Formulations of an Intramuscular A/H5N1 Inactivated, Split Virion Influenza Adjuvanted VaccineWho this might be right forInfluenzaOrthomyxoviridae Infections Sanofi 375